Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study
CONCLUSIONS: The difference in risk of recurrence between primary stage TaG1 and PUNLMP stands in contrast to the recently adapted notion that treatment and follow-up strategies can be merged into one low-risk group of NMIBC.PMID:34623216 | DOI:10.1080/21681805.2021.1987980
Source: Scandinavian Journal of Urology - Category: Urology & Nephrology Authors: Johannes Bobjer Oskar Hagberg Firas Aljabery Truls G årdmark Staffan Jahnson Tomas Jerlstr öm Amir Sherif Athanasious Simoulis Viveka Str öck Christel H äggström Lars Holmberg Fredrik Liedberg Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Education | Health Management | PET Scan | Study | Sweden Health | Urology & Nephrology